Results 241 to 250 of about 112,423 (291)
Some of the next articles are maybe not open access.
New England Journal of Medicine, 1980
Metronidazole is currently approved for use against Trichomonas infection and amebiasis. It is also effective against giardiasis, "nonspecific vaginitis," and anaerobic infections and bactericidal against almost all obligately anaerobic organisms; Actinomyces, Arachnia, and Propionibacterium are exceptions.
exaly +3 more sources
Metronidazole is currently approved for use against Trichomonas infection and amebiasis. It is also effective against giardiasis, "nonspecific vaginitis," and anaerobic infections and bactericidal against almost all obligately anaerobic organisms; Actinomyces, Arachnia, and Propionibacterium are exceptions.
exaly +3 more sources
Mayo Clinic Proceedings, 1987
Metronidazole, a nitroimidazole derivative, is a unique antimicrobial agent that is active against both bacterial and parasitic organisms, although only the anaerobic members of these groups are susceptible. It has been used for the treatment of trichomoniasis for about 20 years and is also effective against amebiasis and giardiasis.
J E, Rosenblatt, R S, Edson
openaire +4 more sources
Metronidazole, a nitroimidazole derivative, is a unique antimicrobial agent that is active against both bacterial and parasitic organisms, although only the anaerobic members of these groups are susceptible. It has been used for the treatment of trichomoniasis for about 20 years and is also effective against amebiasis and giardiasis.
J E, Rosenblatt, R S, Edson
openaire +4 more sources
Obstetrics and Gynecology Clinics of North America, 1992
Metronidazole has proven to be a useful and inexpensive antibiotic for the treatment of T. vaginalis and bacterial vaginosis. Few alternatives exist for these two specific indications, and metronidazole will continue to play a primary role in therapy. Oral metronidazole continues to be a very inexpensive alternative to oral vancomycin for the treatment
W D, Hager, R P, Rapp
openaire +3 more sources
Metronidazole has proven to be a useful and inexpensive antibiotic for the treatment of T. vaginalis and bacterial vaginosis. Few alternatives exist for these two specific indications, and metronidazole will continue to play a primary role in therapy. Oral metronidazole continues to be a very inexpensive alternative to oral vancomycin for the treatment
W D, Hager, R P, Rapp
openaire +3 more sources
Infection Control, 1986
Metronidazole was introduced to the market in 1959 as the only effective therapy forTrichomonas vaginalis. A nitroimidazole derivative, its success in the therapy of parasitic infections, includingEntamoeba histolyticaandGiardia lamblia, has been well documented.
+5 more sources
Metronidazole was introduced to the market in 1959 as the only effective therapy forTrichomonas vaginalis. A nitroimidazole derivative, its success in the therapy of parasitic infections, includingEntamoeba histolyticaandGiardia lamblia, has been well documented.
+5 more sources
Medical Clinics of North America, 1988
Metronidazole is a highly effective therapy for anaerobic infections and a variety of protozoal and parasitic diseases. Its pharmacokinetics, toxicities, and unique mode of action are reviewed in detail. Indications for use and respective dosages are suggested.
openaire +3 more sources
Metronidazole is a highly effective therapy for anaerobic infections and a variety of protozoal and parasitic diseases. Its pharmacokinetics, toxicities, and unique mode of action are reviewed in detail. Indications for use and respective dosages are suggested.
openaire +3 more sources
Metronidazole Hypersensitivity
Annals of Pharmacotherapy, 1994OBJECTIVE: To report a case of a possible hypersensitivity reaction induced by metronidazole. CASE SUMMARY: An Asian woman with a history of recurrent vaginitis had previously developed localized erythema while on intravaginal metronidazole and nystatin.
S, Knowles, T, Choudhury, N H, Shear
openaire +2 more sources